Obesity-induced down-regulation of the mitochondrial translocator protein (TSPO) impairs placental steroid production

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 1, 2015, Pages E11-E18

  Lassance, Luciana ^a   Haghiac, Maricela ^a   Minium, Judi ^a   Catalano, Patrick ^a   Mouzon, Sylvie Hauguel De ^a  

^a METROHEALTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CITRATE SYNTHASE; ESTRADIOL; GLUCOSE; INSULIN; LEPTIN; LIPOPOLYSACCHARIDE; MITOCHONDRIAL DNA; PROGESTERONE; SATURATED FATTY ACID; STEROIDOGENIC ACUTE REGULATORY PROTEIN; TRANSLOCATOR PROTEIN; UNCLASSIFIED DRUG; 4 AMINOBUTYRIC ACID RECEPTOR; CHOLESTEROL; GLUCOSE BLOOD LEVEL; TSPO PROTEIN, HUMAN;

ADULT; ARTICLE; CESAREAN SECTION; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MATERNAL BLOOD; MATERNAL OBESITY; OHIO; PLACENTA WEIGHT; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROTEIN EXPRESSION; STEROIDOGENESIS; TROPHOBLAST; UMBILICAL CORD BLOOD; BIOSYNTHESIS; DOWN REGULATION; GENETICS; GLUCOSE BLOOD LEVEL; METABOLISM; OBESITY; PHYSIOLOGY; PLACENTA; PREGNANCY; YOUNG ADULT;

ADULT; BLOOD GLUCOSE; CHOLESTEROL; DOWN-REGULATION; ESTRADIOL; FEMALE; HUMANS; INSULIN; LEPTIN; OBESITY; PLACENTA; PREGNANCY; PROGESTERONE; RECEPTORS, GABA; YOUNG ADULT;

EID: 84983401095     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-2792     Document Type: Article

References (40)

1. Mesiano S. Myometrial progesterone responsiveness and the control of human parturition. J Soc Gynecol Investig. 2004;11(4):193-202.
2. Challis JRG, Matthews SG, Gibb W, Lye SJ. Endocrine and paracrine regulation of birth at term and preterm. Endocr Rev. 2000; 21(5):514-550.
3. Tuckey RC. Progesterone synthesis by the human placenta. Placenta. 2005;26(4):273-281.
4. Xu XF, Bjorntorp P. The effects of steroid hormones on adipocyte development. Int J Obes. 1990;14(suppl 3):159-163.
5. Pedersen SB, Kristensen K, Hermann PA, Katzenellenbogen JA, Richelsen B. Estrogen controls lipolysis by up-regulating α2A-adrenergic receptors directly in human adipose tissue through the estrogen receptor α. Implications for the female fat distribution. J Clin Endocrinol Metab. 2004;89(4):1869-1878.
6. Lizcano F, Guzman G. Estrogen deficiency and the origin of obesity during menopause. BioMed Res Int. 2014;2014:757461.
7. Clegg DJ. Minireview: the year in review of estrogen regulation of metabolism. Mol Endocrinol. 2012;26(12):1957-1960.
8. Mauvais-Jarvis F. Estrogen and androgen receptors: regulators of fuel homeostasis and emerging targets for diabetes and obesity. Trends Endocrinol Metab. 2011;22(1):24-33.
9. Moog-Lutz C, Tomasetto C, Regnier CH, et al. MLN64 exhibits homology with the steroidogenic acute regulatory protein (STAR) and is over-expressed in human breast carcinomas. Int J Cancer. 1997;71(2):183-191.
10. Papadopoulos V, Baraldi M, Guilarte TR, et al. Translocator protein (18 kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci. 2006;27(8):402-409.
11. Batarseh A, Papadopoulos V. Regulation of translocator protein 18 kDa (TSPO) expression in health and disease states. Mol Cell Endocrinol. 2010;327(1-2):1-12.
12. Thompson MM, Manning HC, Ellacott KL. Translocator protein 18 kDa (TSPO) is regulated in white and brown adipose tissue by obesity. PloS One. 2013;8(11):e79980.
13. Sivitz WI, Yorek MA. Mitochondrial dysfunction in diabetes: from molecular mechanisms to functional significance and therapeutic opportunities. Antiox Redox Signal. 2010;12(4):537-577.
14. Catalano PM, Thomas AJ, Avallone DA, Amini SB. Anthropometric estimation of neonatal body composition. Am J Obstet Gynecol. 1995;173(4):1176-1181.
15. Kliman HJ, Nestler JE, Sermasi E, Sanger JM, Strauss JF 3rd. Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae. Endocrinology. 1986; 118(4):1567-1582.
16. Matsuoka Y, Srere PA. Kinetic studies of citrate synthase from rat kidney and rat brain. J Biol Chem. 1973;248(23):8022- 8030.
17. Liapis A, Chen FW, Davies JP, Wang R, Ioannou YA. MLN64 transport to the late endosome is regulated by binding to 14-3-3 via a non-canonical binding site. PloS One. 2012;7(4):e34424.
18. Fan J, Lindemann P, Feuilloley MG, Papadopoulos V. Structural and functional evolution of the translocator protein (18 kDa). Curr Mol Med. 2012;12(4):369-386.
19. Allen JA, Diemer T, Janus P, Hales KH, Hales DB. Bacterial endotoxin lipopolysaccharide and reactive oxygen species inhibit Leydig cell steroidogenesis via perturbation of mitochondria. Endocrine. 2004;25(3):265-275.
20. Basu S, Haghiac M, Surace P, et al. Pregravid obesity associates with increased maternal endotoxemia and metabolic inflammation. Obesity (Silver Spring, Md). 2011;19(3):476-482.
21. Blanchette S, Marceau P, Biron S, Brochu G, Tchernof A. Circulating progesterone and obesity in men. Horm Metab Res. 2006; 38(5):330-335.
22. Pasqualini JR. Enzymes involved in the formation and transformation of steroid hormones in the fetal and placental compartments. J Steroid Biochem Mol Biol. 2005;97(5):401-415.
23. Allen AM, Taylor JM, Graham A. Mitochondrial (dys)function and regulation of macrophage cholesterol efflux. Clin Sci (London, England). 2013;124(8):509-515.
24. Shoukrun R, Veenman L, Shandalov Y, et al. The 18-kDa translocator protein, formerly known as the peripheral-type benzodiazepine receptor, confers proapoptotic and antineoplastic effects in a human colorectal cancer cell line. Pharmacogenet Genomics. 2008; 18(11):977-988.
25. Gatliff J, Campanella M. The 18 kDa translocator protein (TSPO): a new perspective in mitochondrial biology. Curr Mol Med. 2012; 12(4):356-368.
26. Roberts VH, Smith J, McLea SA, Heizer AB, Richardson JL, Myatt L. Effect of increasing maternal body mass index on oxidative and nitrative stress in the human placenta. Placenta. 2009;30(2):169-175.
27. Veenman L, Gavish M. The role of 18 kDa mitochondrial translocator protein (TSPO) in programmed cell death, and effects of steroids on TSPO expression. Curr Mol Med. 2012;12(4):398- 412.
28. Barak Y, Nelson MC, Ong ES, et al. PPAR γ is required for placental, cardiac, and adipose tissue development. Mol Cell. 1999;4(4):585-595.
29. Coll T, Jove M, Rodriguez-Calvo R, et al. Palmitate-mediated downregulation of peroxisome proliferator-activated receptor-γ coactivator 1α in skeletal muscle cells involves MEK1/2 and nuclear factor-κB activation. Diabetes. 2006;55(10):2779-2787.
30. Gazouli M, Yao ZX, Boujrad N, Corton JC, Culty M, Papadopoulos V. Effect of peroxisome proliferators on Leydig cell peripheraltype benzodiazepine receptor gene expression, hormone-stimulated cholesterol transport, and steroidogenesis: role of the peroxisome proliferator-activator receptor α. Endocrinology. 2002;143(7): 2571-2583.
31. Flores-Espinosa P, Pineda-Torres M, Vega-Sanchez R, et al. Progesterone elicits an inhibitory effect upon LPS-induced innate immune response in pre-labor human amniotic epithelium. Am J Reprod Immunol. 2014;71(1):61-72.
32. Pepe G, Albrecht E. Glob. libr. women's med., (ISSN: 1756-2228) 2008; DOI 10.3843/GLOWM.10. Available at: http://www.glowm. com/section-view/item/310.
33. Morishima A, Grumbach MM, Simpson ER, Fisher C, Qin K. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab. 1995;80(12):3689-3698.
34. Riant E, Waget A, Cogo H, Arnal JF, Burcelin R, Gourdy P. Estrogens protect against high-fat diet-induced insulin resistance and glucose intolerance in mice. Endocrinology. 2009;150(5):2109-2117.
35. Barros RP, Gabbi C, Morani A, Warner M, Gustafsson JA. Participation of ERα and ERβ in glucose homeostasis in skeletal muscle and white adipose tissue. Am J Physiol Endocrinol Metab. 2009; 297(1):E124-E133.
36. Mesiano S, Chan EC, Fitter JT, Kwek K, Yeo G, Smith R. Progesterone withdrawal and estrogen activation in human parturition are coordinated by progesterone receptor A expression in the myometrium. J Clin Endocrinol Metab. 2002;87(6):2924-2930.
37. Di Renzo GC, Giardina I, Clerici G, Mattei A, Alajmi AH, Gerli S. The role of progesterone in maternal and fetal medicine. Gynecol Endocrinol. 2012;28(11):925-932.
38. Chien Y, Cheng WC, Wu MR, Jiang ST, Shen CK, Chung BC. Misregulated progesterone secretion and impaired pregnancy in Cyp11a1 transgenic mice. Biol Reprod. 2013;89(4):91.
39. Su L, Sun Y, Ma F, Lu P, Huang H, Zhou J. Progesterone inhibits Toll-like receptor 4-mediated innate immune response in macrophages by suppressing NF-κB activation and enhancing SOCS1 expression. Immunol Lett. 2009;125(2):151-155.
40. Challier JC, Basu S, Bintein T, et al. Obesity in pregnancy stimulates macrophage accumulation and inflammation in the placenta. Placenta. 2008;29(3):274-281.